| ../ | | - | Directory |
| Baltzly.et.al./ | 2026-Sep-03 00:26:36 | - | Directory |
| FC.Acylation/ | 2026-Sep-03 00:26:36 | - | Directory |
| Anise.Oil.Precursor_Microgram.Jan-Dec.2004.pdf | 2026-Sep-03 00:26:36 | 105.2K | application/pdf |
| Barfknecht.Nichols.4Br.MethoxyAmphetamines.pdf | 2026-Sep-03 00:26:36 | 365.4K | application/pdf |
| Barfknecht.Nichols.Potential.Psychotomimetics.Bromomethoxyamphetamines.pdf | 2026-Sep-03 00:26:36 | 142.6K | application/pdf |
| Coutts.Malicky.Preparation.of.Analogues.of.DOM.pdf | 2026-Sep-03 00:26:36 | 727.8K | application/pdf |
| Glennon.Serotinin.Receptor.Properties.4X.DOM.pdf | 2026-Sep-03 00:26:36 | 811.1K | application/pdf |
| Glennon.etal.Behavioral.Properties.4X.DOM.pdf | 2026-Sep-03 00:26:36 | 805.3K | application/pdf |
| Glennon.etal.Cathinone.Analogues.DOB.pdf | 2026-Sep-03 00:26:36 | 142.1K | application/pdf |
| Morin.etal.Behavioral.Effects.of.25.Dimethoxy.4.AlkylAmphetamines.pdf | 2026-Sep-03 00:26:36 | 316.4K | application/pdf |
| Nichols.Shulgin.Sulfur.Analogs.of.Pyschotomimetic.Amines.pdf | 2026-Sep-03 00:26:36 | 655.2K | application/pdf |
| Nichols.etal.4.TFM.2.5.DiMeO.Amphetamine.pdf | 2026-Sep-03 00:26:36 | 859.9K | application/pdf |
| Oberlender.etal.Substituent.Branching.in.PEA.Type.Hallucinogens.pdf | 2026-Sep-03 00:26:36 | 737.9K | application/pdf |
| Sebastian.Study.of.the.Hallucinogen.DON.pdf | 2026-Sep-03 00:26:36 | 561.4K | application/pdf |
| Seggel.etal.SAR.4.Substituted.DOM.Analogues.5HT2A.pdf | 2026-Sep-03 00:26:36 | 787.3K | application/pdf |
| Shulgin.Psychotomimetic.PEAs.4.Alkyl.25Di.MeOPEAs.pdf | 2026-Sep-03 00:26:36 | 515.8K | application/pdf |
| Xu.Chen.Synthesis.D.PEA.derivatives.pdf | 2026-Sep-03 00:26:36 | 158.9K | application/pdf |